Skip to main content

Philips announces first installation of IntelliSpace Critical Care and Anesthesia system at Kasih Ibu Hospital in Bali, Indonesia

November 14, 2019
Philips interoperable digital technology, predictive trend analytics and smart algorithms help drive improved outcomes in acute careAmsterdam, the Netherlands and Jakarta, Indonesia  – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a significant development in the digitization of patient treatment in Indonesia, with the country’s first installation of Philips IntelliSpace Critical Care and Anesthesia (ICCA) system at the Kasih Ibu Hospital in Denpasar, Bali. The critical care technology is part of Philips’ broader connected care suite aimed to help ensure seamless care and timely information flow between patients and the healthcare professionals who provide treatment. At Kasih Ibu Hospital, the critical care system will be integrated with Philips Patient Deterioration Solution – a portfolio of solutions to help manage patient deterioration outside the ICU – to better track patient conditions, helping the hospital achieve improved patient care, enhanced patient experience, lower costs and better staff satisfaction. Leveraging digital technology to help advance acute critical care
The Intensive Care Unit (ICU) workflow is quite complex, involving admission/discharge, daily routine care, emergency, and unscheduled events, as well as managing end of life care. The sheer numbers of medications, scans, treatments, and tests administered pose a huge burden on patients and their loved ones, and the complex workflow demands a huge effort from all clinical teams involved. It is estimated there are 178 processes delivered to each ICU patient per day, with 1.7 of them associated with some error [1]. For those teams, decision-making becomes a complex yet time-critical process, made even more difficult by data-overload caused by disparate devices, patient record systems and data sources.  
Digitization of healthcare services, especially in hospitals treating emergency and post-surgical patients, is a pressing need worldwide as hospitals cope with meeting surging healthcare demand while not compromising the quality of care and patient safety. As hospitals across the globe team with industry to improve and save lives, Indonesia is no exception. Acute care is particularly challenging, associated with the highest number of medical errors. Nearly all ICU patients suffer a potentially life-threatening error during their stay, with medication errors accounting for 78% of serious medical errors [2]. Decision-making and diagnosis are also more difficult in critical care due to the vulnerability of patients, who can have co-morbidities and deteriorate rapidly.“Philips is helping to shape the future of healthcare by providing smart patient care and clinical intelligence where and when needed,” said Carla Kriwet, Chief Business Leader of Connected Care at Philips. “With solutions like Philips IntelliSpace Critical Care and Anesthesia, we are combining patient monitoring with connected technology, to help deliver more consistent patient care, seamless patient transitions and improved care. We are committed to help hospitals across Indonesia apply connected care technology to help both patients and medical teams.”“Kasih Ibu Hospital aspires to become a smart hospital, at the forefront of leveraging health technology innovations, especially in digitization of patient care, in order to meet domestic and foreign patient expectations,” said Krishnawenda Duarsa, President of Kasih Ibu Hospital Group. “We believe our investment in these solutions will help improve our service quality and patient treatment, allowing our medical staff to focus on providing the right care at the right time to help drive improved patient outcomes and better operational efficiency.”Interoperable digitalized hospital systems for faster and more accurate treatment
Philips IntelliSpace Critical Care and Anesthesia is an advanced clinical decision support and automatic documentation solution, providing analytics, integrated care management and reporting throughout the ICU care cycle. The system centralizes and organizes patient data – including admission documents, vital signs, labs, and consult notes – to help transform patient data into actionable insights, enabling connectivity between medical devices in the ICU to help improve outcomes.
Early Warning Scoring leads to identification of clinical deterioration
The Philips Patient Deterioration Solution consists of an integrated suite of devices, wearable sensors, software, and professional services. The customizable solution is integrated with the hospital EMR (electronic medical record) to help enhance organizational efficiencies and current infrastructure investments.  The solution aims to enable caregivers to effectively identify and proactively respond to patient deterioration in hospital wards, help reduce the risk of missed signs of deterioration, improve patient care, and increase efficiencies in patient management and workflow [3].
Leveraging intelligent algorithms and predictive trend analytics, the solution, including IntelliVue GuardianSoftware, helps clinicians identify patient deterioration, notify caregivers and enable appropriate, timely intervention to prioritize patient care. As part of Philips’ goal of improving the lives of 3 billion people a year by 2030, more than 275 million patients are monitored with Philips’ patient monitors each year. Abnormal vital signs or other indications of clinical instability typically appear eight to twelve hours prior to critical event [3]. Through the use of Philips IntelliVue Guardian Software, an automated early warning scoring (EWS) and workflow system, clinicians receive information to help identify subtle warning signs of a patient’s physiological decline for timely intervention.[1] Donchin, Y. et al. A look into the nature and causes of human errors in the intensive care unit. BMJ Qual. Saf. 12, 143–147 (2003).
[2] Rothschild, J. M. et al. The Critical Care Safety Study: The incidence and nature of adverse events and serious medical errors in intensive care. Crit. Care Med. 33, 1694–1700 (2005).
[3] Early warning scoring can aid in identifying subtle warning signs of physiological decline 6 to 8 hours before an event (Incidence, staff awareness and mortality of patients at risk on general wards. Fuhrmann L, Lippert A, Perner A, Østergaard D. Resuscitation. 2008 Jun;77(3):325-30. Epub 2008 Mar 14. PMID: 18342422 [PubMed – indexed for MEDLINE])
[4] http://www.euro.who.int/en/health-topics/Health-systems/patient-safety/data-and-statistics
For further information, please contact:Kathy O’Reilly
Philips Global Press Office
Tel.: +1 978-221-8919
E-mail: Kathy.oreilly@philips.com  
Twitter: @kathyoreilly
Yulin Febrina
Philips Indonesia
Tel: +62 2965 1330
E-mail: yulin.febrina@philips.com
About Royal Philips

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.